InvestorBrandNetwork (IBN) Content Platform

Siyata Mobile (NASDAQ: SYTA), a global provider of innovative Push-to-Talk (“PTT”) over Cellular (“PoC”) and cellular signal booster solutions, is slated to attend Critical Communications World 2023 (“CCW”). The company will also exhibit at the event, which is scheduled for May 23–25, 2023, in Helsinki, Finland. The two-day conference and expo is designed to gather together mission-critical and business-critical end users with manufacturers and suppliers to share inspiration, knowledge and connections. According to the announcement, CCW is a global networking hub, allowing visitors to view the latest technology and forge new business relationships with partners from across the globe. “We aim to become a premier, global provider of PTT solutions and are building out a robust ecosystem of distributors, partners and manufacturers to support this goal,” said Siyata Mobile founder and CEO Marc Seelenfreund in the press release. “Sales of SD7, our powerful push-to-talk communications solution, are beginning to accelerate, particularly in Europe, and CCW is an excellent venue for us to showcase our solutions, increase brand awareness and attract potential buyers.”

To view the full press release, visit https://ibn.fm/pFjxX

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation Push-to-Talk over cellular devices and cellular booster systems. Its portfolio of in-vehicle and rugged devices enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. The company’s portfolio of enterprise-grade and consumer cellular booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. For more information about the company, visit www.SiyataMobile.com or www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/SYATF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tingo Group Inc. (NASDAQ: TIO), a global fintech and agri-fintech group of companies with operations in Africa, southeast Asia and the Middle East, will be joining the broad-market Russell 3000 Index at the conclusion of the 2023 FTSE Russell indexes annual reconstitution process. According to the announcement, the inclusion is tentatively scheduled to occur after the U.S. markets close on June 23, 2023. The company noted that the annual reconstitution process for the Russell indexes captures the 4,000 largest U.S. stocks, ranking them by total market capitalization. Membership in the index is valid for one year and includes automatic inclusion in the Large-Cap Russell 1000(R) Index or Small-Cap Russell 2000(R) Index as well, depending on a company’s growth and value style indexes. Many investment managers and institutional investors use the indexes as benchmarks for active investment strategies. FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide by calculating thousands of indexes in more than 70 countries, covering 98% of the investable market globally. An estimated $20.1 trillion is benchmarked to FTSE Russell indexes.

To view the full press release, visit https://ibn.fm/SgL9M

About Tingo Group Inc.

Tingo Group is a global fintech and agri-fintech group of companies with operations in Africa, southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is the leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a device-as-a-service smartphone and preloaded platform product. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing the farmers with access to services such as the Nwassa seed-to-sale marketplace platform, insurance, microfinance, and mobile phone and data top-up. Tingo Group’s other Tingo business verticals include TingoPay, a SuperApp in partnership with Visa that offers a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food-processing business that processes raw foods into finished products such as rice, pasta and noodles; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China, with more than 130 offices located in China’s cities and major towns; and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore. For more information, visit the company’s website at www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/TMNA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Fresh2 Group (NASDAQ: ANPC), formerly AnPac Bio-Medical Science Co., a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, will be changing its ticker symbol on May 22, 2023. The company announced that its ticker symbol will change to FRES (“FRES”) at the open of market trading that day. “Transitioning to the ticker FRES is the most recent step we have taken toward our strategic initiative to focus on the recently engaged, new business line of business-to-business food trade and delivery platform for U.S. local restaurants and supermarkets,” said Fresh2 Group co-CEO Haohan Xu in the press release. “The ticker symbol change aligns with our new brand identity in the U.S. food market and reflects our vision for the future. We believe that we are well positioned to increase our presence in the new business sector with scalable business model and look forward to our future with confidence.”

To view the full press release, visit https://ibn.fm/5cGYj

About Fresh2 Group Limited

Fresh2 Group Limited is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of March 31, 2023. With two certified clinical laboratories in China and one CLIA and CAP accredited clinical laboratory in the United States, Fresh2 performs a suite of cancer screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. The company is entering the business-to-business e-commerce food business with the formation of its wholly owned subsidiary Fresh2 Technology Inc and the acquisition of Fresh2 Ecommerce Inc. For more information about the company, visit www.Fresh2.co

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

The PaxMedica (NASDAQ: PXMD) team recently gathered to ring the closing bell on the NASDAQ exchange, where its shares began trading in August 2022. The April 19 event coincided with Autism Awareness Month. “We’re aggressively working towards our most important goal: developing the first treatment for the core symptoms of autism spectrum disorder, and we will not stop until we get there,” PaxMedica CEO Howard Weisman said in his opening remarks.

For more information, visit https://ibn.fm/fs6fv

About PaxMedica Inc.

PaxMedica is a clinical stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms. These range from neurodevelopmental disorders, including autism spectrum disorder (“ASD”), to myalgic encephalomyelitis/chronic fatigue syndrome (“ME/CFS”), a debilitating physical and cognitive disorder believed to be viral in origin and now with rising incidence globally due to the long term effects of SARS-CoV-2 (“COVID-19”). One of PaxMedica’s primary points of focus is the development and testing of its lead program, PAX-101, an intravenous formulation of suramin, in the treatment of ASD and the advancement of the clinical understanding of using that agent against other disorders such as ME/CFS and long COVID-19 syndrome, a clinical diagnosis in individuals who have been previously infected with COVID-19. For more information, visit www.PaxMedica.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Informa, an international events, digital services and academic knowledge group, has announced that NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company part of IBN (“InvestorBrandNetwork”) will once again serve as the official newswire for FinovateSpring. The three-day event is slated for May 23–25, 2023, and will be returning to an in-person format; it will be held in San Francisco. According to the announcement, the prestigious gathering is designed to provide the more than 1,200 participants with relevant and essential information regarding cutting-edge technologies in the world of global finance as well as a detailed roadmap for building a competitive edge in the rapidly changing space. This year’s FinovateSpring will feature more than 100 recognized experts in the field who will each share invaluable information, insight and perspectives in a variety of formats, including keynotes, general sessions, panel discussions and fireside chats. Attendees will include C-suite executives and senior leadership from marquee financial institutions, disruptive innovators, fintech pioneers, media representatives and civil servants. In its role as the event’s official newswire, IBN will focus on heightening recognition and awareness of the event along with its speakers, startup founders and exhibitors. “We are always pleased to collaborate with IBN and NNW,” said Finovate VP Greg Palmer in the press release. “They have consistently helped make Finovate’s events a greater success and extend the influence of each conference far beyond the on-site venues. Through their social media coverage and outreach capabilities, IBN positions us well to reach larger online audiences as we drive meaningful relationships among our growing number of attendees and exhibitors.”

To participate in the event, visit https://ibn.fm/xUuko

To view the full press release, visit https://ibn.fm/HzNxN

About Finovate

A subsidiary of Informa Connect, Finovate is a research and events firm focused on innovation in financial and banking technology. Its team runs the Finovate conference series and authors the popular Finovate blog. Finovate is the only conference series focused exclusively on showcasing the best and most innovative new financial and banking technologies. Finovate conferences consistently attract large, high-impact audiences of senior financial and banking executives, venture capitalists, press, industry analysts, bloggers, regulators and entrepreneurs. For more information about the company and event, visit www.Finovate.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), the digital face of the plant-based community operating a one-stop shop for plant-based products, announced that Tofutti Brands has joined the growing roster of brands that have adopted its e-commerce fulfillment solutions. The new partnership means that Tofutti now features a “Shop PlantX” banner across the top of its website that directs customers to a branded landing page. PlantX sells and fulfills a wide selection of Tofutti products, including sour cream guacamole, ricotta cheese, soy American cheese and several of its cream cheese varieties; these products are shipped directly from the PlantX warehouse. The announcement also noted that Tofutti products are available on PlantX’s sister website, veganessentials.com, one of the most established domains in the vegan space. “We are humbled that the company that started it all in the dairy-free foods has chosen PlantX as its ecommerce partner for its full line of plant-based, dairy-free, vegan products,” said PlantX Life CEO Lorne Rapkin in the press release. “The company was plant based before plant based was cool and has amassed a large and very loyal following in its over 40 years in business, in which it has built a brand well-known throughout the globe. When these customers go to make a purchase online on the Tofutti website, they will now be directed to shop on plantx.com. We’re thrilled.”

To view the full press release, visit https://ibn.fm/gZDBx

About PlantX Life Inc.

PlantX is committed to being the digital face of the plant-based community as well as the one-stop shop for plant-based products. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. PlantX also has other brands in the PlantX portfolio, including a juice brand, a coffee company, a plant shop, and brick-and-mortar grocery stores. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, to provide education. PlantX’s digital presence works to eliminate the barriers for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier, and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DSG Global (OTCQB: DSGT) today announced expansion of its North American head office, sales and operations with a tripling of the square footage to facilitate the growth requirements of all product lines in Q3 and beyond. The company signed a new three-year lease agreement for administrative staff, engineering dept, warehouse in Surrey and a new lease for assembly facility for all golf cart assembly in Lakeland, Florida, and storage facility in Sacramento, California. “Even though our expansion in Surrey is in the same building, we had the opportunity to acquire much needed office space and retain our existing space that is now dedicated to engineering and installations,” said Bob Silzer, CEO. “We are at key juncture in our growth plan with multiple new products coming to market in Q2 and Q3 /2023, and this was necessary to ensure we had adequate physical plant and office space to support the integration of new personnel from installers to executives. We prioritize maintaining quality standards, ensuring that our products/services continue to meet and exceed customer expectations. We invest in scaling our infrastructure, bolstering our resources to support and facilitate the coming activities in Q3 and Q4.”

To view the full press release, visit https://ibn.fm/c8xOM

About DSG Global Inc.

DSG Global was founded over 10 years ago by the team that was one of the original pioneers of the GPS golf fleet management industry. DSGT will continue to offer the industry leading GPS Management System to operators worldwide under the Vantage-Tag brand. The company has three distinct brands to deliver on the explosive opportunities in the LSV (low speed electric vehicle) and HSV (high speed electric vehicle) markets. Liteborne Motor Company will address the HSV market with the new Aurium SEV (sport electric vehicle) and many other vehicles in the pipeline including buses and commercial vehicles. The LSV market will be supported and expanded by the established Vantage Tag Systems brand, building on the 10-year track record of innovation in the marketspace with a comprehensive product lineup of GPS Fleet Management integrated carts for golf operators, to the legendary Shelby golf and multi-passenger carts for consumers and designated golf communities.

NOTE TO INVESTORS: The latest news and updates relating to DSGT are available in the company’s newsroom at https://ibn.fm/DSGT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global health market, and MedOne Pharmacy Benefit Solutions (“PBM”), a national leader in modern pharmacy benefits management, today announced a new agreement to integrate Dario’s suite of digital health solutions as a complement to MedOne’s digital diabetes solution, the Diabetes Care Path. According to the update, the collaboration will enhance the patient-facing support services for diabetic patients while the MedOne clinical team focuses on interventions with prescribers to optimize treatment plans. “Helping employers manage the growing costs of chronic conditions requires thinking beyond traditional cost containment measures. This new agreement is a great example of how digital health can be deployed at scale to engage members with innovative and proven solutions to improve outcomes and reduce costs,” said Rick Anderson, president of Dario. “We are excited to launch Dario’s solutions to MedOne members, aligning the proven value of Dario with a forward-thinking PBM to help employers achieve better results.”

To view the full press release, visit https://ibn.fm/A2vq2

About DarioHealth Corp.

DarioHealth is a leading digital health company, revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Its platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. Dario’s user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to health care. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and consumers. To learn more about Dario and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Processa Pharmaceuticals (NASDAQ: PCSA) today announced its receipt of guidance from the U.S. Food and Drug Administration (“FDA”) regarding the company’s next trial for Next Generation Chemotherapy-Capecitabine (“NGC-Cap”). The phase 2 safety-efficacy trial will study a combination of PCS6422 and capecitabine for colorectal cancer patients following the principles of FDA’s Project Optimus Oncology Initiative, the recent FDA recommendation on how oncology drugs are to be developed going forward. “Our communications with the FDA have been extremely productive,” said David Young, Pharm.D., Ph.D., Processa’s president and CEO. “One of the most important advantages of NGC-Cap and all our NGC drugs is that they have been designed to decrease the side effects associated with the treatment while increasing the exposure of cancer cells to proven cancer-killing molecules. These changes are expected to increase the number of patients who will benefit from each NGC drug given fewer side effects as well as have a significant impact on a patient’s response.”

To view the full press release, visit https://ibn.fm/lKP0s

About Processa Pharmaceuticals Inc.

Processa is a clinical stage pharmaceutical company focused on developing Next Generation Chemotherapy (“NGC”) drugs intended to improve the safety, tolerability and efficacy of cancer treatment. Some of the key advantages of Processa’s NGCs are expected to be fewer patients experiencing side effects that lead to dose discontinuation, more significant cancer response, and an increase in the number of patients who will benefit from each NGC drug. The NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of these FDA-approved drugs while maintaining the existing mechanisms of killing the cancer cells. By combining the proven cancer-killing active molecules and the Processa Regulatory Science Approach with FDA’s new Project Optimus Oncology Initiative, Processa can provide better therapeutic options to cancer patients more efficiently while increasing the probability of FDA approval. Using its Regulatory Science Approach, the Processa team has consistently demonstrated its ability to obtain FDA approvals as evidenced by over 30 approvals for indications across almost every division of the FDA. The company’s pipeline includes three Next Generation Chemotherapy oncology treatments: Next Generation Capecitabine (“PCS6422” and capecitabine to treat metastatic colorectal, gastrointestinal, breast, pancreatic, and other cancers), Next Generation Gemcitabine (“PCS3117” to treat pancreatic, biliary duct, lung, ovarian, breast, and other cancers), and Next Generation Irinotecan (“PCS11T” to treat lung, colorectal, gastrointestinal, pancreatic, and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Uranium Energy (NYSE American: UEC), the fastest growing supplier of the fuel for the green energy transition to a low carbon future, today announced the appointment of James Hatley as vice president of production, Canada. Hatley brings 25 years of mining experience, including uranium and base metals mine development, construction and operations. He most recently led the construction of three mines at one of Canada’s largest mining projects, the Voisey’s Bay Mine Expansion for Vale. “We are pleased to welcome James Hatley to our production team to develop our Canadian assets including the Roughrider Project, which is an exciting catalyst for UEC in Eastern Athabasca and anchors our Canadian high-grade conventional pipeline,” said Amir Adnani, UEC’s president and CEO.

To view the full press release, visit https://ibn.fm/5waTD

About Uranium Energy Corp.

Uranium Energy is the fastest growing supplier of the fuel for the green energy transition to a low carbon future. UEC is the largest, diversified North American focused uranium company, advancing the next generation of low-cost, environmentally friendly In-Situ Recovery (“ISR”) mining uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready ISR hub-and-spoke platforms in South Texas and Wyoming. These platforms are anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, the company has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of U.S. warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a pipeline of resource stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Amesite (NASDAQ: AMST) is a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets. Amesite today announced that it is extending its partnership with EWIE Group of Companies (“EGC”), a global leader in commodity management services and supply chain optimization with over 30 years of experience. According to the update, the continued partnership will deliver enterprise upskilling needs for EGC’s global teams on EGC’s proprietary Learning Community Environment(R) – powered by Amesite. “We conduct training all over the world that needs to be delivered with efficiency and effectiveness,” said EGC Director of Technology Subin Babu. “Working with Amesite has enabled us to launch and run our programs with excellence, and we are very pleased to continue this strong relationship.”

To view the full press release, visit https://ibn.fm/s2rJy

About Amesite Inc.

Amesite delivers its scalable, customizable, white-labeled online learning platform to universities, businesses, museums and government agencies, enabling them to deliver outstanding digital learning. Amesite provides a single system that combines eCommerce, instruction, engagement, analytics, and administration using best-in-class infrastructure to serve multibillion-dollar online learning markets. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vision Sensing Acquisition Corp. (NASDAQ: VSAC), a special purpose acquisition company, is working with Newsight Imaging Ltd. on a planned business combination. Newsight CEO Eli Assoolin talks about the merger in the latest release from the Bell2Bell podcast series. Newsight Imaging is a leading semiconductor innovator that is focused on developing proprietary 3D machine vision sensors, spectral vision chips and systems. During the episode, Assoolin shares his background and journey to Newsight while also providing background on the VSAC business collaboration and insight into the potential for the semiconductor space. Bell2Bell is a podcast series released by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community. “About a year-and-a-half ago, we were looking at how to bring Newsight into its next phase — how to rebrand the company and land in the U.S. while making us a better choice for our customers,” said Newsight CEO Eli Assoolin during the interview. “We came to the conclusion that we needed to go public somewhere. Eventually, Vision Sensing found us and submitted an offer to merge. Since then, we’ve been working together on a merger that’s expected to be completed soon.”

To view the full episode, visit https://ibn.fm/J0VX6

To view the full press release, visit https://ibn.fm/FJKYH

About Vision Sensing Acquisition Corp.

Vision Sensing Acquisition Corp. is a Special Purpose Acquisition Company (“SPAC”) that has been established to focus on the acquisition of vision-sensing technologies, including hardware solutions (chips/modules/systems), related application software, artificial intelligence and other peripheral technologies that assist to integrate and/or supplement VST applications. For more information about the company, please visit www.Vision-Sensing.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sharing Services Global Corporation (OTCQB: SHRG) today announced that its wholly owned subsidiary, MyTravelVentures, just completed its inaugural Venture Trip at the Sensira Resort and Spa in Cancun, Mexico. MyTravelVentures, a subscription-based travel company that offers access to wholesale travel savings for any consumer, provides its members full access to exclusive deals across the travel industry. This includes savings of up to 65% on services like flights, hotels, transportation and events, as well as nontravel-related services such as retailer discounts, cash-back programs and telehealth services. “We couldn’t be more excited about our first Venture Trip in Cancun,” said MyTravelVentures VP Dave Dove. “It was the ultimate getaway. We had over 50 members in attendance, an amazing resort, a 10-course meal at the Galerie des Sans restaurant, a poker night and so much more. And the best part, hands down, was connecting with such a diverse and fun community of people.”

To view the full press release, visit https://ibn.fm/H19NI

About Sharing Services Global Corporation

Sharing Services is a publicly traded diversified company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. The Sharing Services combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer. Additional information is contained in the company’s 10-Q and 10-K filings with the Securities and Exchange Commission. For more information, visit www.SHRGInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Truleo, a company that processes body camera videos for police departments across the country to help automate supervision, facilitate coaching and promote police professionalism, is hosting a Q&A webinar. The webinar is slated to begin at 1:30 p.m. PST on May 30, 2023. According to the announcement, the webinar will include a live demo by Truleo CEO Anthony Tassone, who will highlight the company’s cutting-edge body cam analytics and explain how the analytics work for both good and bad police behavior. Truleo is dedicated to increasing trust in the police through body camera analytics, and the company’s revolutionary technology and analytics detect, record and review unprofessional police encounters. As a result, Truleo clients report a 36% decrease in use-of-force incidents. The company provides cutting-edge tech that uses natural language processing to analyze audio on an officer’s body camera while also determining when conflict-based events may have occurred during a call for service. In addition, the platform scores an officer’s language and offers suggestions for improvements.

To view the webinar, visit https://ibn.fm/CeLOA

To view the full press release, visit https://ibn.fm/NtyMd

About Truleo

Truleo has created a cutting-edge body camera analytics platform. The company’s revolutionary technology automatically processes 100% of BWC data and produces timely, actionable reports. For more information about the company, visit www.Truleo.co

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global provider of innovative of push-to-talk over cellular (“PoC”) and cellular signal booster solutions, today announced its entry into a distribution agreement for its next-generation MCPTT (mission critical push-to-talk) solution with KPN Royal Dutch Telecom (“KPN”), a leading telecommunications and IT provider in the Netherlands. “This distribution agreement expands the reach of our SD7 handset through wireless carriers to a new geographic region and opens new opportunities for growth,” said Marc Seelenfreund, Siyata CEO. “Aligning with quality wireless carriers is an important aspect of our growth strategy. As an innovator and telecommunications leader in the Netherlands and one of the largest wireless carriers in Europe, KPN has extensive experience in the push-to-talk technology space and is highly focused on offering the best solutions for its customers. We are eager to leverage their established channels to provide more end users with our powerful MCPTT solution.”

To view the full press release, visit https://ibn.fm/d7Y1b

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation push-to-talk over cellular (“PoC”) devices and cellular booster systems. Its in-vehicle and rugged devices enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. Its portfolio of enterprise grade and consumer cellular booster systems enables first responders and enterprise workers to amplify cellular signals in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. Siyata’s common shares and previously issued warrants trade on the Nasdaq under the symbols SYTA and SYTAW, respectively. For more information about the company, visit www.SiyataMobile.com and UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Fresh2 Group Limited (NASDAQ: ANPC), formerly AnPac Bio-Medical Science Co., a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, is releasing financial results for first quarter 2023 as well as fiscal year 2022; the company also announced that it filed its annual report on for the fiscal year ended December 31, 2022 , with the U.S. Securities and Exchange Commission. The unaudited results include notable numbers, including total revenue for Q1 2023 came in at approximately RMB593,000 ($87,000), down 69.9% from the same period of 2022; gross profit margin was 25% for the first quarter of 2023; and the average selling price (“ASP”) of CDA-based tests was RMB330 ($48.1), an increase of RMB97.0 , or 41.6% from  same period of 2022. FY 2022 reported numbers included total revenues of RMB12.0 million ($1.7 million ), down 33% from the previous year, gross margin was 69.2%, a slight increase from 2021, and the ASP of CDA-based tests was RMB266 ($39) in the year ended December 31, 2022. The company noted key business highlights in the reports, including continued validation regarding the efficacy of CDA testing through clinical study follow-ups, the filing of 260 patent applications globally, and the continued progress on building a cancer risk assessment database, which currently includes an estimated 286,472 samples.

“We have been actively exploring new business opportunities to diversify our revenue stream, despite the unfavorable macro environment for our existing biotech business,” said Fresh2 Group co-CEO Haohan Xu in the press release. “Currently, we are striving to build a leading e-commerce platform in the U.S. that offers online wholesale food supplies for restaurants and supermarkets. We are committed to helping restaurants and supermarkets reduce procurement costs and increase efficiency by utilizing an intelligent supply chain management system. We will allow our customers to directly connect with reliable suppliers, ensuring that the food purchased is consistent in quality with competitive prices, and the source of the food can be determined. We have opened our platform to multiple categories of suppliers, while also providing a comprehensive supply chain service. By leveraging digital technology and innovative business models, we intend to drive the online transformation of the food supply industry. We believe our growth strategy positions us well to develop a customer base, generate a steady revenue stream and improve our profitability in the long run. Looking forward, we will continue to focus on implementing our growth strategies and invest in our business to capture the massive opportunities we see in the U.S. market.”

To view the full press releases, visit https://ibn.fm/n1AFn, https://ibn.fm/7HysR and https://ibn.fm/zLo9m

About Fresh2 Group Limited

Fresh2 Group Limited is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of March 31, 2023. With two certified clinical laboratories in China and one CLIA and CAP accredited clinical laboratory in the United States, Fresh2 performs a suite of cancer screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. The Company is entering the business-to-business e-commerce food business with the formation of its wholly owned subsidiary Fresh2 Technology Inc and the acquisition of Fresh2 Ecommerce Inc. For more information about the company, visit www.Fresh2.co

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vivos Therapeutics (NASDAQ: VVOS) chairman and CEO Kirk Huntsman recently joined Natalie Stoberman from the Proactive Studio to discuss how the company’s POD device performed a highly effective rate in treating migraine headaches in a clinical study. During the interview, Huntsman said that the study showed 92% of patients reporting complete resolution of their symptoms, an unprecedented result for a non-pharmaceutical application in this field. He further expanded upon the device’s potential for other applications, such as treating upper airway resistance, TMD, bruxism, and various pain conditions, which require further research. Huntsman additionally discussed Vivos’ implementation of a broad set of initiatives aimed at improving operational efficiencies, reducing expenses and positioning Vivos to take advantage of current growth opportunities. The company projects it could hit the positive cashflow milestone at the beginning of 2024.

To view the full press release, visit https://ibn.fm/WPD3U

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) and snoring in adults. The Vivos Method represents the first clinically effective nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild-to-moderate OSA. It has proven effective in over 33,000 patients treated worldwide by more than 1,750 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and/or palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using The Vivos Method. For more information, visit www.Vivos.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sharing Services Global Corporation (OTCQB: SHRG) and DSS Inc. (NYSE American: DSS) recently announced the distribution date for the common stock of Sharing Services that is beneficially held by DSS directly and through its subsidiary, Decentralized Sharing Systems Inc. (“DSSI”). According to the announcement, each share of DSS common stock outstanding as of 5 p.m. ET held on April 28, 2023, entitled the holder to receive two SHRG common stock shares distributed on May 4, 2023. As a result, DSS and DSSI hold an approximate 7% ownership interest in Sharing Services Global Corporation.

DSS, a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, today announced its financial results for the first quarter 2023. “We are very pleased by the company’s progress in substantially reducing our operating costs and continuing to optimize our businesses towards profitability,” said Todd Macko, CFO of DSS. “Our Premier Packaging division had a stellar quarter in booking a 72% increase in revenues in the first quarter compared to the first quarter of 2022 as a result of our capital investments completed over the past year.”

To view the full press release, visit https://ibn.fm/2BQl2

About Sharing Services Global Corporation

Sharing Services is a publicly traded company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies in the direct-selling sector and other industries. Sharing Services’ combined platform currently leverages the capabilities and expertise of various companies that market and sell products direct to the consumer through independent contractors. For more information, visit www.SHRGInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Guardforce AI (NASDAQ: GFAI, GFAIW), an integrated security provider specializing in secured logistics, AI and Robot-as-a-Service (“RaaS”), has announced the closing of its underwritten public offering of 2,580,600 ordinary shares, par value of $0.12 per share, each at a public offering price of $4.65. The underwriters exercised the over-allotment option in full for an additional 387,090 ordinary shares at the time of the closing. As a result, Guardforce AI secured aggregate gross proceeds of approximately $13.8 million prior to deducting underwriting discounts and other offering expenses. EF Hutton, division of Benchmark Investments LLC, acted as the lead book-running manager and Spartan Capital Securities LLC acted as the co-manager for the offering.

To view the full press release, visit https://ibn.fm/TRXO8

About Guardforce AI Co. Ltd.

Guardforce AI is a global security solutions provider, building on its legacy secured logistic business while expanding and transforming into an integrated AI and Robot-as-a-Service (“RaaS”) business. With more than 40 years of professional experience and a strong customer foundation, Guardforce AI is developing RaaS solutions that improve operational efficiency, quickly establishing its presence in the Asia Pacific region, while expanding globally. For more information, visit www.GuardforceAI.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide biotherapeutics, nutraceuticals, cosmeceuticals, food and beverage, and other industries. The company today reported record quarterly financial results for any fiscal quarter achieved in the first quarter ended March 31, 2023. In addition, the company provided a business update and offered guidance for expected pivotal achievements through 2023. “During the first quarter of 2023, the PBIO Team was terrifically effective in setting the stage for what we expect to be a year of rapid revenue growth, with significant expansion of both our customer base and product listing, strengthening of our financial framework, and recognition of our revolutionary UltraShear technology as the best-in-class nanoemulsion processing platform worldwide,” PBIO Director of Marketing and Sales John B. Hollister said in the news release.

To view the full press release, visit https://ibn.fm/lFlda

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high-pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, and agrochemical, as well as food and beverage manufacturing. The company’s products utilize both constant and alternating pressure. Pressure BioSciences’ patented enabling technology platform, Pressure Cycling Technology (“PCT”), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are beginning to be widely used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterrorism applications. The company has recently expanded its market opportunities with the acquisition of the BaroFold(TM) patented technology platform, allowing it to enter the bio-pharma contract services and GMP manufacturing equipment sector. Pressure BioSciences has also developed the scalable and high-efficiency pressure-based UltraShear Technology(TM) (UltraShear(TM) or UST(TM)) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, will be participating at the 18th annual Needham Technology & Media Conference, which is scheduled for May 18, 2023. The company announced that CFO Joe Sigrist will be presenting during the conference; Sigrist’s presentation is slated to begin at 12:45 p.m. ET. The announcement also noted that Sigrist would host virtual one-on-one and group meetings throughout the day as scheduled. An archived version of Sigrist’s presentation will be available on the company’s website for 90 days following the event.

To view the presentation, visit https://ibn.fm/9dxlP

To view the full press release, visit https://ibn.fm/YoXJv

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multiformat interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. DDI’s flagship title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games. For more information about this company, please visit www.DoubleDownInteractive.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

QSAM Biosciences (OTCQB: QSAM), a clinical stage biotechnology company developing next-generation therapeutic radiopharmaceuticals, has announced a partnership with RLS (USA) Inc., the third-largest nuclear medicine pharmacy network in the country. The two companies have a commercial supply and clinical dose preparation agreement for the therapeutic radiopharmaceutical drug candidate CycloSam(R) (Samarium-153 DOTMP), a promising clinical-stage treatment for metastatic and primary bone cancer in adults and children. The partnership is the latest in a series of RLS efforts to expand its industry-leading CDMO business and clinical trial capability with radiopharmaceutical partners across the United States. According to the announcement, QSAM is enrolling patients with metastatic bone cancer in a phase I clinical trial evaluating CycloSam; the trial will be conducted in three clinical sites in the United States with additional sites anticipated.

The agreement supports the rapid and efficient preparation of CycloSam doses in compliance with strict industry quality control systems, for patient administration in both current and future clinical trials; the agreement includes an option to expand to commercial scale if CycloSam is approved by the FDA. “We believe the short half-life of Samarium-153 with respect to patient exposure, toxicity and tolerability makes it an ideal drug to treat bone cancers,” said QSAM CEO and cofounder Douglas R. Baum in the press release. “The ability to meet the potential demand requires a pharmacy network capable of preparing and timely delivering patient doses for administration. The RLS network of 31 radiopharmacies across 18 states adds significant geographic coverage and infrastructure to our supply chain, along with an unprecedented level of on-the-ground expertise and credibility as the only accredited radiopharmacy network in the country. Choosing RLS as a partner will not only bolster our current and near-term clinical trials, but it may also provide the initial groundwork for eventual commercial supply and distribution.”

To view the full press release, visit https://ibn.fm/dkmNf

About QSAM Biosciences Inc.

QSAM Biosciences is developing next-generation nuclear medicines for the treatment of cancer and other diseases. QSAM’s initial technology, CycloSam (Samarium-153 DOTMP), is a clinical-stage, bone-targeting radiopharmaceutical developed by IsoTherapeutics Group LLC, pioneers in the nuclear medicine space that also developed the FDA-approved Quadramet(R) (Samarium-153 EDTMP) radiopharmaceutical product. The QSAM team has designed the CycloSam product with the goal of overcoming the limitations of the Quadramet(R) (Samarium-153 EDTMP) product and potentially expand the FDA-approved indications. QSAM is led by an experienced executive team and board of directors that have completed numerous FDA approvals and multiple successful biotech exits. CycloSam has demonstrated preliminary safety and efficacy in animal studies and a single-patient, FDA-cleared human trial performed in 2020 at the Cleveland Clinic. This nuclear technology uses low specific activity Samarium-153 (resulting in far less undesirable europium impurity) and DOTMP, which is highly targeted and actively drawn to areas of high bone turnover, making it, in management’s opinion based on scientific studies, an ideal agent to treat primary and secondary bone cancers. Since CycloSam delivers targeted radiation selectively to the skeletal system and to bone tumors, it is also believed to be a great potential candidate for future effectiveness in clinical trials in bone marrow ablation as preconditioning for bone marrow transplantation as well as its future clinical trials in procedures to reduce external beam radiation to bone tumors. This multipatented drug candidate utilizes a radioisotope previously approved by the FDA, combined with a novel targeting chelant, DOTMP, that has demonstrated preliminary increased efficacy and decreased side effects in animal models and veterinary treatment of bone cancer in dogs. Further, CycloSam utilizes a streamlined, just-in-time manufacturing process that is already in place. Given these factors, management believes there is a strong pathway to commercialization for CycloSam. For more information about the company, please visit www.QSAMBio.com

NOTE TO INVESTORS: The latest news and updates relating to QSAM are available in the company’s newsroom at http://ibn.fm/QSAM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global vendor of push-to-talk over cellular (“PoC”) devices and cellular signal booster systems, today announced its financial results for the three and twelve months ended Dec. 31, 2022. All amounts are stated in U.S. dollars unless otherwise indicated. “We delivered top-line growth of 9% in the fourth quarter of 2022 on strengthening sales of our mission-critical PoC (‘MCPTT’) SD7 solution,” said Marc Seelenfreund, founder and CEO of Siyata. “Following the successful launch of our SD7 mid-year, total sales for the devices and related accessories exceeded $3 million in the second half of 2022. Recent orders in multiple verticals and particularly in the large-scale education vertical demonstrate the growing adoption of our solutions. Importantly, we are establishing ourselves in new markets beyond our core of first responders and emergency personnel with new distribution channels, particularly in North America, that we believe will drive our business to an inflection point as volumes continue to increase. Our pipeline of new opportunities continues to grow, and we expect the impact of the progress we are making will be more evident in our financial results in 2023.”

To view the full press release, visit https://ibn.fm/0ngzI

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation push-to-talk over cellular (“PoC”) devices and cellular booster systems. Its in-vehicle and rugged devices enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. Its portfolio of enterprise grade and consumer cellular booster systems enables first responders and enterprise workers to amplify cellular signals in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. Siyata’s common shares and previously issued warrants trade on the Nasdaq under the symbols SYTA and SYTAW, respectively. For more information about the company, visit www.SiyataMobile.com and UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA          

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Red White & Bloom (CSE: RWB) (OTC: RWBYF) today announced that it has filed its consolidated audited financial statements, management’s discussion and analysis (“MD&A”) and associated certifications. Among the highlights of the results for fiscal 2022, the company reported an increase in annual revenue to $97.5 million, a 260% increase from $37.3 million for fiscal 2021. In addition, RWB reported $27.6 million in gross profit after fair value adjustments for fiscal 2022, a $4.4 million increase as compared to fiscal 2021. The company has also provided notice to the British Columbia Securities Commission (“BCSC”) of the aforementioned filings to commence the process of lifting the Cease Trade Order (“CTO”) implemented by the BCSC on May 8, 2023. Revocation of the CTO is expected within a few days of today’s filing date.

“With the successful launch of our distribution operations in Michigan in January 2022, the closing of our acquisition in Michigan of both retail and cultivation operations, and our continuing focus on expanding our medical retail in Florida, the company is focused on growing market share in its key states,” said RWB CEO and Chairman Brad Rogers. “We are also progressing on our asset-light strategies in targeted legal states incorporating both licensing arrangements and leveraging local execution capabilities in both manufacturing and logistics. To that end, RWB has now added the states of Arizona and Missouri and continues to proactively negotiate other high-potential, emerging legal markets.”

To view the full press release, visit https://ibn.fm/uWlc1

About Red White & Bloom Brands Inc.

Red White & Bloom is a multistate cannabis operator and house of premium brands in the U.S. legal cannabis sector. RWB is predominantly focusing its investments on the major U.S. markets, including Arizona, California, Florida, Massachusetts, Missouri, and Michigan. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PowerTap Hydrogen Capital (NEO: MOVE) (OTC: MOTNF), a leading provider of on-site hydrogen production technology, and its subsidiary, PowerTap Hydrogen Fueling Corp., has entered a memorandum of understanding (“MOU”) with LuftCar Corp., a U.S.-based, hydrogen-powered electric vertical takeoff and landing (“eVTOL”) vehicle manufacturer. The agreement is related to PowerTap’s sale and LuftCar’s purchase of hydrogen produced at future PowerTap and/or PowerTap-LuftCar colocated hydrogen-production facilities. According to the announcement, the collaboration will promote the adoption of hydrogen fuel cell technology for air, road and utility backup refueling and will advance Connecticut’s commitment to sustainable transportation and clean-energy solutions. Some specifics of the agreement, such as location of sales, volume and price are subject to a definitive agreement between the two companies. The announcement did note that the companies are working to establish a network of hydrogen refueling stations across Connecticut to support the fueling needs of eVTOLs, road vehicles and utility backup systems. In addition, the company also announces its financial results for the quarter ended March 31, 2023. Those results, along with the accompanying management discussion and analysis, have been filed on SEDAR. “We are excited to join forces with LuftCar to promote hydrogen fuel cell technology in Connecticut,” said PowerTap Hydrogen Fueling Corp. CEO Salim Rahemtulla in the press release. “Our on-site hydrogen fueling stations, coupled with LuftCar’s cutting-edge eVTOLs, will provide a comprehensive solution for clean and efficient transportation and cargo distribution in the state, paving the way for a greener and more sustainable future.”

To view the full press releases, visit https://ibn.fm/1w9n4 and https://ibn.fm/bIE82

About PowerTap Hydrogen Capital Corp.

PowerTap Hydrogen, through its wholly owned subsidiary PowerTap Hydrogen Fueling Corp., is focused on installing hydrogen production and dispensing fueling infrastructure in the United States. PowerTap’s patented solution has been developed over 20 years. PowerTap is now commercializing its third-generation blue-hydrogen product, which will focus on the refueling needs of the automotive and long-haul trucking markets that lack hydrogen fueling infrastructure. For more information about the company, please visit www.CleanPower.Capital.

NOTE TO INVESTORS: The latest news and updates relating to MOTNF are available in the company’s newsroom at https://ibn.fm/MOTNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sigma Additive Solutions (NASDAQ: SASI), a leading provider of quality assurance software to the commercial 3D printing industry, is reporting its financial and operational results for the first quarter ended March 31, 2023. Highlights of the report include news that during the quarter, the company expanded its collaboration for connected software solutions with Materialise, a global leader in 3D printing software and service solutions; expanded software into post processing with DyeMansion, the global leader in connected and integrated post-processing solutions for industrial polymer 3D-printing; and is continuing to work toward the launch of software-only solutions to support OEM, hardware and software partner integrations. Financial numbers in the report included Q1 revenue of $130,159 compared to revenues of $51,844 for the first quarter of 2022; gross profit for the quarter was $66,495, compared to $11,753 in the same quarter the previous year; total operating expenses for Q1 2023 were $1.8 million, compared to $2.3 million in 2022, a decrease of 19%; and cash used in operating activities for the three months ended March 31, 2023 totaled $1.3 million as compared to $2.0 million in the three months ended March 31, 2022.

“During the first quarter, we continued to focus on expanding the industry partnerships that are critical to the growth of our software-only solutions, targeted for release in Q2 2023,” said Sigma president and CEO Jacob Brunsberg in the press release. “We believe that these collaborations would unlock market potential and expand the total addressable market that could drive our company forward. . . . In parallel, we continue to work with Lake Street Capital Markets on the exploration of a variety of strategic alternatives designed to enhance shareholder value, including a possible strategic investment, acquisition, merger, business combination, or similar transaction. We look forward to providing additional updates in the months to come as we seek to make progress on our evolution to a subscription pricing model and transform to software only product options.”

To view the full press release, visit https://ibn.fm/QEJhy

About Sigma Additive Solutions

Sigma Additive Solutions is a leading provider of in-process quality assurance (“IPQA”) solutions to the additive manufacturing industry. Sigma specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D(R) for 3D metal and polymer advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real time during the manufacturing process, enabling significant cost savings and production efficiencies by reducing waste, increasing yield and shortening cycle times. Sigma believes its software solutions will be a major catalyst for the acceleration and adoption of industrial 3D printing. For more information about the company, please visit www.SigmaAdditive.com.

NOTE TO INVESTORS: The latest news and updates relating to SASI are available in the company’s newsroom at http://ibn.fm/SASI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

For over a decade, FinovateSpring has attracted the best and brightest on and off the stage, including decision-makers from across the financial services spectrum, including banks, brokerages, card issuers, payment providers, investment companies, insurance providers, and everything in between. This year’s FinovateSpring event continues the tradition, but this time in a new venue – Marriot Marquis San Francisco.

More than 50+ live demos are scheduled for FinovateSpring, spread across two days on May 23-25, 2023 – themed to include personal/retail, business, backend/enabling, and outside-a-box technology. These demos are hand-selected to showcase their services and solutions, not just pitch them, showing…

Read More>>

To learn more, please visit https://ibn.fm/rTYQ6.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Predictive Oncology (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence (“AI”) and machine learning capabilities, extensive biorepository of tumor samples, CLI laboratory and GMP facility, to accelerate oncologic drug discovery and enable drug development, is reporting on its financial and operating results for the three months ended March 31, 2023. According to the report, the company saw a net loss of $3.4 million on total net revenue of $0.2 million for the first quarter 2023, with gross profit margin decreasing to 50% during the quarter three months ended March 31, 2023, compared to 65% in the same period in 2022, and G&A expenses totaling $2,335,984 Q1 2023, compared to $2,423,651 for Q1 2022. Business highlights included a groundbreaking partnership with Cancer Research Horizons to drive the development of oncology drugs utilizing Predictive Oncology’s PEDAL(TM) platform as well as a collaboration with Integra Therapeutics and key changes in board membership and company leadership. The company also partnered with Cvergenx to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using AI and launched its Accelerating Compound Exploration (“ACE”) program to partner with academic and research institutions to advance their drug-discovery efforts.

“We are very pleased to have delivered a strong first quarter, announcing three meaningful contracts with Cvergenx, Cancer Research Horizons and Integra Therapeutics, that all seek to leverage our unique portfolio of assets and capabilities to expedite early drug discovery and enable drug development,” said Predictive Oncology CEO and chair Raymond F. Vennare in the press release. “As a highly differentiated leader in the field of AI-assisted drug discovery, we are in the very early stages of addressing a billion-dollar industry that is estimated to be growing 30% annually. I believe the steps that we have taken to this point position us very well to play a meaningful role in the development of new oncology drugs, which will not only benefit cancer patients but also create long-term value for our shareholders. I am excited for what we can achieve this year.”

To view the full press release, visit https://ibn.fm/Z0mEz

About Predictive Oncology Inc.

Predictive Oncology is on the cutting-edge of the rapidly growing use of artificial intelligence (“AI”) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. With PEDAL and the company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based, drug-discovery solutions, further complimented by its wholly owned CLIA lab and GMP facilities. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Flora Growth (NASDAQ: FLGC), a global cultivator, manufacturer and distributor of cannabis products and brands is reporting on its financial and operating results for the quarter ended March 31, 2023. Highlights of the report note that Flora generated $20.1 million in revenue during the quarter, a 307% increase year-over-year, with gross profit for the quarter up 105% year-over-year, totaling $5.5 million. The company also reported a net loss of $3.9 million for the quarter, a decrease from the same quarter in 2022.“As I take the reins of the organization, I am pleased to share the results of the first quarter of 2023, which included increased revenue generation for the company,” said Flora Growth newly appointed CEO Hussein Rakine in the press release. “The first quarter was focused on strengthening our operational performance, focusing on financial discipline and optimizing the integrations of all our M&A transactions. Our House of Brands continued to be the primary revenue-generating pillar, posting sequential growth and steady margins. Our Commercial and Wholesale division was positively impacted by the addition of our German distribution business while our pharmaceutical initiatives continued to progress. However, the first quarter was not without its challenges, which included impediments in our ability to export cannabis from Cosechemos, delays in the realization of operating expense reductions, and the prior period’s M&A-related transaction costs and liabilities, all affecting both the company’s liquidity position and ability to fully realize our strategic plan for the quarter. . . . My priority is to further optimize the organization, reduce spend and focus on organic growth in revenue areas, which offer the highest margin contribution and return on investment.”

To view the full press release, visit https://ibn.fm/XIsyp

About Flora Growth Corp.

Flora Growth Corp. is a global cannabis company dedicated to bringing the benefits of cannabis to people worldwide. The company’s commitment is to create, master and connect the international cannabis supply chain by setting the standard for world-class cultivation and manufacturing, thoughtful brand development, and rigorous research and development of medical-grade cannabis products that meet the highest standards of quality, safety and efficacy. Flora Growth’s mission is to create a world where the benefits of cannabis are accessible to everyone, and the company is working toward that goal by becoming a leading importer and exporter of cannabis to meet demand in every corner of the market. For more information about the company, please visit www www.FloraGrowth.com

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is reporting on its financial results for the quarter ended March 31, 2023. According to the report, the company is focused on continuing to expand its drug procurement marketplace nationwide, with an estimated 1,100 new members joining the platform during the first quarter of 2023, resulting in total registered members reaching more than 14,500 by quarter end. Financial numbers from the report show consolidated revenues for Q1 2023 decreased 31% to $2.2 million with gross profit analysis of comparable fiscal periods in both 2023 and 2022 reflecting an increase in gross profits of $221,000 for Q1 2023 compared to 2022. Operating expenses for the quarter reached $1.9 million with the company reporting a net loss of ($0.7) million compared to a net loss of ($1.0) million for same period in 2022. Adjusted EBITDA came in at ($0.06) million for the quarter 2023, compared to ($0.7) million for the first quarter 2022. “The first three months of 2023 have been an exciting and challenging time for TRxADE,” said TRxADE Health founder and CEO Suren Ajjarapu in the press release. “We continue to focus the company’s strategic plans and partnerships, working towards creating sustainable value for our stockholders. I am pleased with the growth we have experienced in our TRxADE platform. We continue to achieve key milestones in our internal roadmap with a focus on innovation and development through our various complementary growth opportunities.”

To view the full press release, visit https://ibn.fm/GjkNl

About TRxADE Health Inc

TRxADE Health is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug procurement marketplace serving more than 14,500 members nationwide, fostering price transparency and, under the Bonum Health brand, offering patient-centric telehealth services. For more information about the company, please visit www.Trxade.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Exro Technologies (TSX: EXRO) (OTCQB: EXROF), a leading clean-technology company that develops new-generation power-control electronics that expand the capabilities of electric motors and batteries, has signed a definitive commercialization agreement with Linamar Corporation (TSX: LNR), a global tier-1 automotive supplier. The agreement outlines the two companies’ plans to serially produce and commercialize an integrated electric beam axle product for class 3-6 vehicles. According to the announcement, the agreement will begin with an initial five-year term and includes the building of a product demonstration vehicle; the agreement also grants Linamar exclusive rights to Exro’s Coil Driver(TM) product for use in medium-duty class 3–6 electric beam axle applications. “We are thrilled to achieve this next major milestone with Linamar,” said Exro CEO Sue Ozdemir in the press release. “The signing of the definitive agreement demonstrates steady progress with a leading tier-1 OEM supplier, further validates the potential of our technology and signals to shareholders an opportunity for a material increase in production volume in the years ahead. Linamar has been a great partner, and we look forward to advancing this combined product to commercialization.”

In addition, Exro announced that it has entered into an agreement with a syndicate of Canadian underwriters for the purchase of 13,500,000 common shares in the capital of the company. Purchase prices of the shares is C$2.25 per common share, resulting in gross proceeds for the company of C$30,375,000. According to the announcement, Exro anticipates using the funds to meet capital expenditure and working capital obligations related to strategic partnership and collaboration agreements as well as for general working capital purposes.

To view the full press releases, visit https://ibn.fm/FxUyj and https://ibn.fm/EuN6p

About Exro Technologies Inc.

Exro Technologies is a leading clean-technology company that has developed new-generation power control electronics that change how the world optimizes energy by expanding the capabilities of electric motors and batteries. The company’s innovative technologies serve to bridge the performance-cost gap in e-mobility (Coil Driver(TM)) and stationary energy storage (Cell Driver(TM)), and act to accelerate adoption toward a circular electrified economy by delivering more with less — minimum energy for maximum results. For more information about the company, please visit www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sharing Services Global (OTCQB: SHRG) and its wholly owned subsidiary, The Happy Co., have unveiled a new probiotic dietary supplement product: Probio8. The Happy Co. is a leading producer and distributor of nootropic, functional beverage products with a focus on health and wellness. Gluten-free, sugar-free and vegan, Probio8 is delivered in capsule form and contains eight different strains of beneficial probiotics, prebiotics and postbiotics. According to the announcement, the new potent formula, which includes updated packaging, is an enhancement offering compared to the company’s previous probiotic supplement. “The pursuit of exceptional health is central to everything we do here,” said Sharing Services Global CEO John “JT” Thatch in the press release. “We know that gut health is foundational to overall wellness, so developing a product as powerful as Probio8 means our customers have the greatest possible advantage when it comes to achieving their personal health goals. We’ve never been content to rest on the success of our existing products alone. We’re committed to always expanding and improving what we do. Probio8 is a great example of how, even with our best products, we’re always looking for opportunities to innovate and to serve our customers better.”

To view the full press release, visit https://ibn.fm/0aelV

About Sharing Services Global Corporation

Sharing Services Global is a publicly traded diversified company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. The Sharing Services combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer. For more information about the company, please visit www.SHRGInc.com or www.TheHappyCo.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork